标题
An update on gene therapy for lysosomal storage disorders
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-16
出版商
Informa UK Limited
发表日期
2019-05-07
DOI
10.1080/14712598.2019.1607837
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Brain‐targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms
- (2018) Hélène FE Gleitz et al. EMBO Molecular Medicine
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Systemic delivery of AAVB1-GAA clears glycogen and prolongs survival in a mouse model of Pompe disease
- (2018) Allison May Keeler et al. HUMAN GENE THERAPY
- AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)
- (2018) Allison M. Bradbury et al. HUMAN GENE THERAPY
- AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease
- (2018) Michael P Hughes et al. HUMAN MOLECULAR GENETICS
- Liver-based expression of the human alpha-galactosidase A gene in a murine Fabry model results in continuous therapeutic levels of enzyme activity and effective substrate reduction
- (2018) Marshall W. Huston et al. MOLECULAR GENETICS AND METABOLISM
- ZFN-mediated in vivo genome editing results in therapeutic levels of α-galactosidase A and effective substrate reduction in Fabry knockout mice
- (2018) Silvere Pagant et al. MOLECULAR GENETICS AND METABOLISM
- ZFN-mediated in vivo genome editing of hepatocytes results in phenotypic correction in murine MPS I and MPS II models
- (2018) Thomas Wechsler et al. MOLECULAR GENETICS AND METABOLISM
- ASGCT 21st Annual Meeting Abstracts
- (2018) MOLECULAR THERAPY
- A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
- (2018) Hiroyuki Sonoda et al. MOLECULAR THERAPY
- Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
- (2018) Kanut Laoharawee et al. MOLECULAR THERAPY
- Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
- (2018) Zachary Fitzpatrick et al. Molecular Therapy-Methods & Clinical Development
- A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice
- (2018) Hongjie Wang et al. Molecular Therapy-Methods & Clinical Development
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life
- (2018) Nicholas Bascou et al. Orphanet Journal of Rare Diseases
- Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
- (2018) Amine Meliani et al. Nature Communications
- Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression
- (2017) M L Katz et al. GENE THERAPY
- Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System–Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer
- (2017) Kanut Laoharawee et al. HUMAN GENE THERAPY
- Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I
- (2017) Lalitha R. Belur et al. HUMAN GENE THERAPY
- S/MAR Element Facilitates Episomal Long-Term Persistence of Adeno-Associated Virus Vector Genomes in Proliferating Cells
- (2017) Claudia Hagedorn et al. HUMAN GENE THERAPY
- Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial
- (2017) Marc Tardieu et al. LANCET NEUROLOGY
- A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease
- (2017) Andrew Talbot et al. MOLECULAR GENETICS AND METABOLISM
- Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
- (2017) Alessandra Biffi MOLECULAR THERAPY
- Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
- (2017) Florian Eichler et al. NEW ENGLAND JOURNAL OF MEDICINE
- A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
- (2017) Barry J. Byrne et al. Orphanet Journal of Rare Diseases
- Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion
- (2017) Longping Victor Tse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
- (2017) Francesco Puzzo et al. Science Translational Medicine
- Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI
- (2017) Rita Ferla et al. Molecular Therapy-Methods & Clinical Development
- Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34 + Cells for Correction of Fabry Disease
- (2017) Ju Huang et al. Molecular Therapy-Methods & Clinical Development
- Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells
- (2017) Alessia Capotondo et al. Science Advances
- In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors
- (2016) M. Richter et al. BLOOD
- Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel
- (2016) Mark Tarnopolsky et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease
- (2016) Rebecca E.H. Whiting et al. EXPERIMENTAL EYE RESEARCH
- Preclinical Testing of the Safety and Tolerability of Lentiviral Vector–Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies
- (2016) Ilaria Visigalli et al. HUMAN GENE THERAPY
- Adeno-Associated Virus Gene Therapy for Liver Disease
- (2016) Lisa M. Kattenhorn et al. HUMAN GENE THERAPY
- Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease
- (2016) Phillip A. Doerfler et al. HUMAN GENE THERAPY
- The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disorders
- (2016) A. Broomfield et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
- (2016) Maria Sessa et al. LANCET
- AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II
- (2016) Ah-Ra Ko et al. MOLECULAR GENETICS AND METABOLISM
- Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy
- (2016) Vasco Meneghini et al. Stem Cells Translational Medicine
- Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery
- (2016) Haiyan Fu et al. Molecular Therapy-Methods & Clinical Development
- Manufacturing of recombinant adeno-associated viral vectors for clinical trials
- (2016) Nathalie Clément et al. Molecular Therapy-Methods & Clinical Development
- Engineering the AAV capsid to optimize vector–host-interactions
- (2015) Hildegard Büning et al. CURRENT OPINION IN PHARMACOLOGY
- Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice
- (2015) Maria Dahl et al. MOLECULAR THERAPY
- Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
- (2015) Jean-Charles Nault et al. NATURE GENETICS
- Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates
- (2015) Michel Zerah et al. Human Gene Therapy Clinical Development
- Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
- (2015) Manuela Corti et al. Human Gene Therapy Clinical Development
- Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA
- (2015) Jean-Baptiste Dupont et al. Molecular Therapy-Methods & Clinical Development
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Correction of murine mucopolysaccharidosis type IIIA central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery
- (2014) Chantelle McIntyre et al. JOURNAL OF GENE MEDICINE
- Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo
- (2014) Daniela Cesana et al. MOLECULAR THERAPY
- Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I
- (2014) C. Hinderer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of gene transfer for induction of antigen-specific tolerance
- (2014) Brandon K Sack et al. Molecular Therapy-Methods & Clinical Development
- Assessment of toxicity and biodistribution of recombinant AAV8 vector–mediated immunomodulatory gene therapy in mice with Pompe disease
- (2014) Gensheng Wang et al. Molecular Therapy-Methods & Clinical Development
- Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
- (2013) D. H. Fowler et al. BLOOD
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice
- (2013) Andrea Annoni et al. EMBO Molecular Medicine
- A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA
- (2013) Nicolina Cristina Sorrentino et al. EMBO Molecular Medicine
- Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes
- (2013) Barbara K. Smith et al. HUMAN GENE THERAPY
- Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
- (2013) Virginia Haurigot et al. JOURNAL OF CLINICAL INVESTIGATION
- Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis
- (2013) Nathan R. Selden et al. Journal of Neurosurgery-Pediatrics
- Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease
- (2013) Ana Sergijenko et al. MOLECULAR THERAPY
- Preclinical Demonstration of Lentiviral Vector-mediated Correction of Immunological and Metabolic Abnormalities in Models of Adenosine Deaminase Deficiency
- (2013) Denise A Carbonaro et al. MOLECULAR THERAPY
- Three-Year Follow-up after Unilateral Subretinal Delivery of Adeno-Associated Virus in Patients with Leber Congenital Amaurosis Type 2
- (2013) Francesco Testa et al. OPHTHALMOLOGY
- Bone Marrow Cell Recruitment to the Brain in the Absence of Irradiation or Parabiosis Bias
- (2013) Katrin Kierdorf et al. PLoS One
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Pre-existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
- (2013) Vedell Louis Jeune et al. Human Gene Therapy Methods
- Infantile Pompe disease on ERT-Update on clinical presentation, musculoskeletal management, and exercise considerations
- (2012) Laura E. Case et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Mesenchymal Stromal Cells: New Directions
- (2012) Armand Keating Cell Stem Cell
- Gene Therapy for Mucopolysaccharidosis Type VI Is Effective in Cats Without Pre-Existing Immunity to AAV8
- (2012) Rita Ferla et al. HUMAN GENE THERAPY
- Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
- (2012) John A. Maga et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Extended Normal Life After AAVrh10-mediated Gene Therapy in the Mouse Model of Krabbe Disease
- (2012) Mohammad A Rafi et al. MOLECULAR THERAPY
- Sialic Acid Deposition Impairs the Utility of AAV9, but Not Peptide-modified AAVs for Brain Gene Therapy in a Mouse Model of Lysosomal Storage Disease
- (2012) Yong Hong Chen et al. MOLECULAR THERAPY
- The AAV Vector Toolkit: Poised at the Clinical Crossroads
- (2012) Aravind Asokan et al. MOLECULAR THERAPY
- Hematopoietic Stem Cell Gene Therapy for the Multisystemic Lysosomal Storage Disorder Cystinosis
- (2012) Frank Harrison et al. MOLECULAR THERAPY
- Lentiviral Transduction of CD34+ Cells Induces Genome-Wide Epigenetic Modifications
- (2012) Yoshiaki Yamagata et al. PLoS One
- Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation
- (2012) A. Capotondo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hematopoietic stem cell expansion and gene therapy
- (2011) Korashon Lynn Watts et al. CYTOTHERAPY
- Mannose-6-phosphate pathway: A review on its role in lysosomal function and dysfunction
- (2011) Maria Francisca Coutinho et al. MOLECULAR GENETICS AND METABOLISM
- A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
- (2011) Virginie Monteilhet et al. MOLECULAR THERAPY
- Systemic Administration of AAV8-α-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic Expression
- (2011) Jennifer B Nietupski et al. MOLECULAR THERAPY
- Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
- (2011) Adam K Bevan et al. MOLECULAR THERAPY
- Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
- (2011) Daniel A. Wolf et al. NEUROBIOLOGY OF DISEASE
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype
- (2010) N. P. van Til et al. BLOOD
- Assessing the potential for AAV vector genotoxicity in a murine model
- (2010) H. Li et al. BLOOD
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Long-term Amelioration of Feline Mucopolysaccharidosis VI After AAV-mediated Liver Gene Transfer
- (2010) Gabriella Cotugno et al. MOLECULAR THERAPY
- New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases
- (2010) Jeffrey H. Grubb et al. REJUVENATION RESEARCH
- Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors
- (2009) Gary C. Pien et al. JOURNAL OF CLINICAL INVESTIGATION
- Adeno-Associated Virus Site-Specific Integration Is Mediated by Proteins of the Nonhomologous End-Joining Pathway
- (2009) S. Daya et al. JOURNAL OF VIROLOGY
- Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease
- (2009) Baodong Sun et al. MOLECULAR THERAPY
- Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy
- (2009) Yong Hong Chen et al. NATURE MEDICINE
- Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis by CNS Administration of a Serotype 2 Adeno-Associated Virus Expressing CLN2 cDNA
- (2008) Stefan Worgall et al. HUMAN GENE THERAPY
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started